Changing the Course of Patient Outcomes in Non-Small-Cell Lung Cancer: Novel Therapeutic Approaches for Early-Stage Disease

In this comprehensive program for oncology professionals learn how the experts are leveraging emerging data on immunotherapy-based approaches for neoadjuvant and adjuvant treatment of early-stage NSCLC including concise text-based modules from multidisciplinary perspectives an on-demand webcast capturing a live CCO community workshop downloadable slidesets and a clinical resource PDF to facilitate shared-decision making with your patients.

Share

Program Content

Activities

Med Onc Perspective: Module
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Medical Oncology Perspective
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 26, 2021

Expires: August 25, 2022

Med Onc Perspective: Slides
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Medical Oncology Perspective
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 26, 2021

Pharmacist Perspective: Module
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: A Pharmacist’s Perspective
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2021

Expires: October 12, 2022

Pharmacist Perspective: Slides
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: A Pharmacist’s Perspective
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2021

Surgeon Perspective: Module
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2021

Expires: November 30, 2022

Surgeon Perspective: Slides
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2021

Activities

IO for Early-Stage NSCLC Slides
Changing the Course of Outcomes in NSCLC: Immunotherapy Approaches for Early-Stage Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 13, 2021

<i>EP</i>: IO for Early-Stage NSCLC
Express Points:
Changing the Course of Outcomes in NSCLC: Immunotherapy Approaches for Early-Stage Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2022

Activities

ICI Early NSCLC Resource
Understanding the Landscape of Immune Checkpoint Inhibitor Therapy in Early-Stage NSCLC: A Shared Decision-Making Resource for Clinicians and Patients
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2021

Activities

IO for Early-Stage NSCLC
Changing the Course of Outcomes in NSCLC: Immunotherapy Approaches for Early-Stage Disease
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 10, 2022

Expires: January 09, 2023

Faculty

cover img faculity

Justin F. Gainor, MD

Associate Professor
Department of Medicine
Harvard Medical School
Assistant in Medicine
Department of Medicine
Director, Center for Thoracic Cancers
Director of Targeted Immunotherapy
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Patrick Forde, MBBCh

Director, Thoracic Oncology Research Program
Oncology Department
Johns Hopkins University
Baltimore, Maryland

cover img faculity

Stefanie L. Houseknecht, PharmD, BCOP

Clinical Pharmacy Specialist
Thoracic Oncology
The Johns Hopkins Hospital and Bayview Medical Center
Baltimore, Maryland

cover img faculity

Elizabeth Krueger, NP

Nurse Practitioner
Thoracic Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

cover img faculity

Jonathan Spicer, MD, PhD, FRCS

Associate Professor of Surgery
Department of Surgery
McGill University
Medical Director
McGill Thoracic Oncology Network
Attending Thoracic Surgeon
Department of Surgery
McGill University Health Center
Montreal, Quebec, Canada

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group